Tharimmune Inc (THAR)
0.3651
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.3651
0.00 (0.00%)
After-Hours: 20:00
Tharimmune Cash from Investing (Quarterly): 0.00 for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
Date | Value |
---|---|
June 30, 2022 | 0.00 |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2021
--
Maximum
Mar 2021
--
Average
--
Median
Mar 2021
Cash from Investing (Quarterly) Benchmarks
Ironwood Pharmaceuticals Inc | -0.068M |
Mirum Pharmaceuticals Inc | -0.013M |
NovaBay Pharmaceuticals Inc | 1.068M |
Palatin Technologies Inc | 0.00 |
iBio Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -2.825M |
Cash from Financing (Quarterly) | 0.3171M |
Free Cash Flow | -6.661M |
Free Cash Flow Per Share (Quarterly) | -0.2403 |
Free Cash Flow Yield | -297.7% |